Asthma trials recruiting in Colorado

All Asthma trials nationally

Cities in Colorado

Recruiting trials in Colorado

• A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
  NCT06664619 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Colorado: Lakewood
• A Study of Depemokimab in Participants of 6 to 11 Years of Age
  NCT07671001 · Phase: Phase 3 · Ages: 6 Years to 11 Years · Sex: All (male and female) · Colorado: Colorado Springs
• A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
  NCT07456033 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Colorado: Aurora
• A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
  NCT07323654 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Colorado: Aurora
• A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
  NCT05757102 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Colorado: Colorado Springs
• A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
  NCT07219173 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Colorado: Colorado Springs
• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
  NCT07276724 · Phase: Phase 3 · Ages: 12 Years to 80 Years · Sex: All (male and female) · Colorado: Colorado Springs
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
  NCT06977581 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Colorado: Colorado Springs
• Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma
  NCT03762395 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Colorado: Aurora
• ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
  NCT07301255 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Colorado: Colorado Springs
• Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
  NCT06307665 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Colorado: Denver
• Individualizing Treatment for Asthma in Primary Care (Full Study)
  NCT07052942 · Phase: Phase 4 · Ages: 13 Years to 75 Years · Sex: All (male and female) · Colorado: Aurora
• Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
  NCT06239844 · Phase: Not applicable (e.g. observational or device study) · Ages: 4 Years to 89 Years · Sex: All (male and female) · Colorado: Aurora
• Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics
  NCT03215836 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · Colorado: Aurora
• PULmonary Stimulation for Asthma Relief
  NCT07709754 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Colorado: Denver
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Colorado: Aurora
• Protocol CAUSE-03 / CHEETAH
  NCT06136091 · Phase: Not specified · Ages: 6 Years to 17 Years · Sex: All (male and female) · Colorado: Aurora
• Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
  NCT06750289 · Phase: Phase 3 · Ages: 12 Years to 75 Years · Sex: All (male and female) · Colorado: Denver
• Reducing Asthma Attacks in Disadvantaged School Children With Asthma
  NCT06003569 · Phase: Not applicable (e.g. observational or device study) · Ages: 5 Years to 12 Years · Sex: All (male and female) · Colorado: Ault, Colorado Springs, Ellicott, Fountain
• Registry of Asthma Characterization and Recruitment 3 (RACR3)
  NCT05272241 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Colorado: Aurora
• Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
  NCT02947945 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Denver
• Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
  NCT07444567 · Phase: Phase 3 · Ages: 6 Years and older · Sex: All (male and female) · Colorado: Aurora
• Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation
  NCT05259904 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Colorado: Denver